Checkpoint inhibitors plus chemotherapy for first-line treatment of advanced non-small cell lung cancer: a systematic review and meta-analysis of randomized controlled trials

BACKGROUND: We conducted a meta-analysis to evaluate the efficacy and safety of upfront add-on immunotherapy for advanced non-small cell lung cancers (NSCLC). METHODS: We performed a literature search on first-line chemotherapy ± immunotherapy in NSCLC. We utilized Revman version 5.3 to calculate th...

Descripción completa

Detalles Bibliográficos
Autores principales: Tun, Aung Myint, Thein, Kyaw Zin, Thein, Wai Lin, Guevara, Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Science Ltd 2019
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787520/
https://www.ncbi.nlm.nih.gov/pubmed/31608159
http://dx.doi.org/10.2144/fsoa-2019-0081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787520/
https://www.ncbi.nlm.nih.gov/pubmed/31608159
http://dx.doi.org/10.2144/fsoa-2019-0081

Ejemplares similares